BiOligo have a comprehensive product and service portfolio across key R&D stages such as gene interference, gene editing, gene expression, and nucleic acid drug delivery. Our star products: Our full-length gRNA kits, based on a professional large-scale synthesis platform, ensure high batch-to-batch consistency (CV <0.44%) and stability, ideal for large-scale and high-throughput library screening.
More >Leading manufacturer of oligos for IVD and gene therapy solutions
查看详情Guided by first principles thinking and lean six sigma management
查看详情
Advancing Biotech Excellence for a Healthier Future.
Founded in 2011, BiOligo Biotechnology (Shanghai) Co., Ltd. is a leading biotech manufacturer dedicated to the R&D of essential raw materials for IVD and gene therapy solutions. Embracing a Lean Six Sigma management approach, Bioligo focuses on pioneering technological advances as well as product innovation.
Historically, large-scale production in the IVD and gene therapy sectors has faced significant challenges due to inconsistency and instability in raw material quality. BiOligo has successfully addressed these critical concerns for its industrial clients, setting new standards in the field and supported the development of advanced, innovative diagnostic/pharmaceutical products.
NEWS CENTER
- 联系我们
- 留言板